Simultaneous identification of multiple β-lactamases in Acinetobacter baumannii in relation to carbapenem and ceftazidime resistance, using liquid chromatography-tandem mass spectrometry

Journal of Clinical Microbiology

Volumn 53, Issue 6, 2015, Pages 1927-1930

  Trip, Hein ^a   Mende, Katrin ^b   Majchrzykiewicz Koehorst, Joanna A ^a,d   Sedee, Norbert J A ^a   Hulst, Albert G ^a   Jansen, Hugo Jan ^c   Murray, Clinton K ^b   Paauw, Armand ^a  

^a TNO   (Netherlands)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^c Ministerie van Defensie   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE OXA 23; BETA LACTAMASE OXA 40; CARBAPENEM; CEFTAZIDIME; IMIPENEM; MEROPENEM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BETA LACTAMASE GENE; BLAADC LIKE GENE; BLACMY 2 LIKE GENE; BLAOXA 23 LIKE GENE; BLAOXA 40 LIKE GENE; BLAOXA 51 LIKE GENE; BROTH MICRODILUTION TEST; COMPARATIVE STUDY; ENZYME ANALYSIS; GENE EXPRESSION; GENE INSERTION SEQUENCE; GENE SEQUENCE; LIQUID CHROMATOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEOMICS; PULSED FIELD GEL ELECTROPHORESIS; SHOTGUN PROTEOMICS; TANDEM MASS SPECTROMETRY; ACINETOBACTER INFECTION; BACTERIUM IDENTIFICATION; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; PEPTIDE MAPPING; PROCEDURES;

ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CARBAPENEMS; CEFTAZIDIME; CHROMATOGRAPHY, LIQUID; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84929359383     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00620-15     Document Type: Article

References (18)

1. Pieper R, Gatlin-Bunai CL, Mongodin EF, Parmar PP, Huang S-T, Clark DJ, Fleischmann RD, Gill SR, Peterson SN. 2006. Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin. Proteomics 6:4246-4258. http://dx.doi.org/10.1002/pmic.200500764.
2. Lange V, Malmstrom JA, Didion J, King NL, Johansson BP, Schafer J, Rameseder J, Wong CH, Deutsch EW, Brusniak MY, Buhlmann P, Bjorck L, Domon B, Aebersold R. 2008. Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol Cell Proteomics 7:1489-1500. http://dx.doi.org/10.1074/mcp.M800032 -MCP200.
3. Carricajo A, Verhoeven PO, Guezzou S, Fonsale N, Aubert G. 2014. Detection of carbapenemase-producing bacteria by using an ultraperformance liquid chromatography-tandem mass spectrometry method. Antimicrob Agents Chemother 58:1231-1234. http://dx.doi.org/10.1128/AAC.01540-13.
4. Carvalhaes CG, Cayô R, Assis DM, Martins ER, Juliano L, Juliano MA, Galesa AC. 2013. Detection of SPM-1-producing Pseudomonas aeruginosa and class D β-lactamase-producing Acinetobacter baumannii isolates by use of liquid chromatography-mass spectrometry and matrixassisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 51:287-290. http://dx.doi.org/10.1128/JCM.02365-12.
5. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
6. Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L. 2012. The success of Acinetobacter species: genetic, metabolic and virulence attributes. PLoS One 7: e46984. http://dx.doi.org/10.1371/journal.pone.0046984.
7. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 54:24-38. http://dx.doi.org/10.1128/AAC.01512-08.
8. Héritier C, Poirel L, Nordmann P. 2006. Cephalosporinase overexpression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 12:123-130. http://dx.doi.org/10.1111/j.1469-0691 .2005.01320.x.
9. Mugnier PD, Poirel L, Nordmann P. 2009. Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J Bacteriol 191:2414-2418. http://dx.doi.org/10.1128/JB.01258-08.
10. Akers KS, Mende K, Yun HC, Hospenthal DR, Beckius ML, Yu X, Murray CK. 2009. Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital. Antimicrob Agents Chemother 53:2693-2695. http://dx.doi.org/10.1128/AAC.01405-08.
11. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electro- phoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43:4328-4335. http://dx.doi.org/10.1128/JCM.43.9.4328-4335 .2005.
12. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. CLSI document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Pope CE, Carter PE, Heffernan HM. 2009. CMY-29 and CMY-30, two novel plasmid-mediated AmpC β-lactamases. Antimicrob Agents Chemother 53:3178. http://dx.doi.org/10.1128/AAC.01586-08.
14. Bogaerts P, Naas T, El Garch F, Cuzon G, Deplano A, Delaire T, Huang TD, Lissoir B, Nordmann P, Glupczynski Y. 2010. GES extendedspectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob Agents Chemother 54:4872-4878. http://dx.doi.org/10.1128/AAC.00871-10.
15. Lopes BS, Evans BA, Amyes SG. 2012. Disruption of the blaOXA-51-like gene by ISAba16 and activation of the blaOXA-58 gene leading to carbapenem resistance in Acinetobacter baumannii Ab244. J Antimicrob Chemother 67:59-63. http://dx.doi.org/10.1093/jac/dkr415.
16. Majchrzykiewicz-Koehorst JA, Heikens E, Trip H, Hulst AG, de Jong AL, Viveen MC, Sedee NJ, van der Plas J, Coenjaerts FE, Paauw A. 2015. Rapid and generic identification of influenza A and other respiratory viruses with mass spectrometry. J Virol Methods 213:75-83. http://dx.doi .org/10.1016/j.jviromet.2014.11.014.
17. Lopes BS, Amyes SG. 2012. Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins. J Med Microbiol 61:1103-1108. http://dx.doi .org/10.1099/jmm.0.044156-0.
18. Poirel L, Cabanne L, Vahaboglu H, Nordmann P. 2005. Genetic environment and expression of the extended-spectrum β-lactamase blaPER-1 gene in Gram-negative bacteria. Antimicrob Agents Chemother 49:1708-1713. http://dx.doi.org/10.1128/AAC.49.5.1708-1713.2005.